you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals

BSE Live

Dec 01, 12:19
892.00 23.95 (2.76%)
Volume
AVERAGE VOLUME
5-Day
154,433
10-Day
137,358
30-Day
160,690
63,776
  • Prev. Close

    868.05

  • Open Price

    870.00

  • Bid Price (Qty.)

    892.00 (80)

  • Offer Price (Qty.)

    892.15 (60)

NSE Live

Dec 01, 12:19
892.00 23.45 (2.70%)
Volume
AVERAGE VOLUME
5-Day
4,443,351
10-Day
3,858,977
30-Day
4,018,324
2,110,738
  • Prev. Close

    868.55

  • Open Price

    876.25

  • Bid Price (Qty.)

    892.00 (119)

  • Offer Price (Qty.)

    892.10 (10)

Strengths (8)
  • High Piotroski Score - Companies with strong financials
  • Company with high TTM EPS Growth
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
  • Company with Low Debt
  • Book Value per share Improving for last 2 years
  • FII / FPI or Institutions increasing their shareholding
  • Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
  • Strong Momentum: Price above short, medium and long term moving averages
Weaknesses (3)
  • MFs decreased their shareholding last quarter
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
Opportunities (6)
  • Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
  • Brokers upgraded recommendation or target price in the past three months
  • Positive Breakout First Resistance ( LTP > R1)
  • Negative to Positive growth in Sales and Profit with Strong Price momentum
  • Highest Recovery from 52 Week Low
  • RSI indicating price strength
Threats (3)
  • Red Flags: Firms linked to ongoing regulatory investigations/legal cases
  • Companies where promoters have increased their pledged stocks
  • Insiders sold stocks
Powered by Trendlyne
Note :Financial Information is based on Consolidated numbers.